Related references
Note: Only part of the references are listed.Heparan sulfate 3-O-sulfation: A rare modification in search of a function
Bryan E. Thacker et al.
MATRIX BIOLOGY (2014)
Heparan sulfate proteoglycan as a cell-surface endocytosis receptor
Helena C. Christianson et al.
MATRIX BIOLOGY (2014)
Zebrafish 3-O-Sulfotransferase-4 Generated Heparan Sulfate Mediates HSV-1 Entry and Spread
Thessicar E. Antoine et al.
PLOS ONE (2014)
Molecular Mediators for Raft-dependent Endocytosis of Syndecan-1, a Highly Conserved, Multifunctional Receptor
Keyang Chen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Self-evolving oxidative stress with identifiable pre- and postmitochondrial phases in PC12 cells
Ganlin Zhang et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2013)
Tau pathology and neurodegeneration
Maria Grazia Spillantini et al.
LANCET NEUROLOGY (2013)
Identification of the Sites of Tau Hyperphosphorylation and Activation of Tau Kinases in Synucleinopathies and Alzheimer's Diseases
Valeriy Duka et al.
PLOS ONE (2013)
Heparan sulfate proteoglycans mediate internalization and propagation of specific proteopathic seeds
Brandon B. Holmes et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
A high-throughput FRET-based assay for determination of Atg4 activity
Min Li et al.
AUTOPHAGY (2012)
Where, when, and in what form does sporadic Alzheimer's disease begin?
Heiko Braak et al.
CURRENT OPINION IN NEUROLOGY (2012)
Heparan Sulfate Biosynthesis: Regulation and Variability
Johan Kreuger et al.
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2012)
Neuronal Membranes are Key to the Pathogenesis of Alzheimer's Disease: the Role of Both Raft and Non-Raft Membrane Domains
R. Williamson et al.
CURRENT ALZHEIMER RESEARCH (2011)
Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease
Paul Hollingworth et al.
NATURE GENETICS (2011)
Tau in Alzheimer Disease and Related Tauopathies
K. Iqbal et al.
CURRENT ALZHEIMER RESEARCH (2010)
Heparan sulfate mediates amyloid-beta internalization and cytotoxicity
Elina Sandwall et al.
GLYCOBIOLOGY (2010)
A zebrafish model of tauopathy allows in vivo imaging of neuronal cell death and drug evaluation
Dominik Paquet et al.
JOURNAL OF CLINICAL INVESTIGATION (2009)
Tetrasulfated Disaccharide Unit in Heparan Sulfate ENZYMATIC FORMATION AND TISSUE DISTRIBUTION
Hideo Mochizuki et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Interactions between the products of the Herpes simplex genome and Alzheimer's disease susceptibility genes: Relevance to pathological-signalling cascades
C. J. Carter
NEUROCHEMISTRY INTERNATIONAL (2008)
Effects of modifiers of glycosaminoglycan biosynthesis on outflow facility in perfusion culture
Kate E. Keller et al.
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE (2008)
Tau phosphorylation sites work in concert to promote neurotoxicity in vivo
Michelle L. Steinhilb et al.
MOLECULAR BIOLOGY OF THE CELL (2007)
Synaptotagmin I and II are present in distinct subsets of central synapses
Michael A. Fox et al.
JOURNAL OF COMPARATIVE NEUROLOGY (2007)
The principal neuronal gD-type 3-O-sulfotransferases and their products in central and peripheral nervous system tissues
Roger Lawrence et al.
MATRIX BIOLOGY (2007)
Quantitative real-time RT-PCR data analysis:: current concepts and the novel gene expression's CT difference formula
Jan H. Schefe et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2006)
Structural impact of heparin binding to full-length Tau as studied by NMR spectroscopy
Nathalie Sibille et al.
BIOCHEMISTRY (2006)
Heparin derivatives as inhibitors of BACE-1, the Alzheimer's β-secretase, with reduced activity against factor Xa and other proteases
Susannah J. Patey et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
Sequential phosphorylation of tau protein by cAMP-dependent protein kinase and SAPK4/p38δ or JNK2 in the presence of heparin generates the AT100 epitope
Hirotaka Yoshida et al.
JOURNAL OF NEUROCHEMISTRY (2006)
Tauopathies: classification and clinical update on neurodegenerative diseases associated with microtubule-associated protein tau
D. R. Williams
INTERNAL MEDICINE JOURNAL (2006)
Syndecan-1 mediates internalization of apoE-VLDL through a low density lipoprotein receptor-related protein (LRP)-independent, non-clathrin-mediated pathway
Larissa C. Wilsie et al.
LIPIDS IN HEALTH AND DISEASE (2006)
Alzheimer disease-specific conformation of hyperphosphorylated paired helical filament-tau is polyubiquitinated through Lys-48, Lys-11, and Lys-6 ubiquitin conjugation
D Cripps et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
A role for heparan sulfate 3-O-sulfotransferase isoform 2 in herpes simplex virus type 1 entry and spread
CD O'Donnell et al.
VIROLOGY (2006)
3-O-sulfated oligosaccharide structures are recognized by anti-heparan sulfate antibody HS4C3
GB ten Dam et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
The RIN: an RNA integrity number for assigning integrity values to RNA measurements
A Schroeder et al.
BMC MOLECULAR BIOLOGY (2006)
Developmental and regional expression of heparan sulfate sulfotransferase genes in the mouse brain
T Yabe et al.
GLYCOBIOLOGY (2005)
Promotion of hyperphosphorylation by frontotemporal dementia tau mutations
AD Alonso et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
β-amyloid induces paired helical filament-like tau filaments in tissue culture
A Ferrari et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Heparan sulphate proteoglycans in Alzheimer's disease and amyloid-related disorders
J van Horssen et al.
LANCET NEUROLOGY (2003)
Human 3 '-phosphoadenosine 5 '-phosphosulfate (PAPS) synthase: Biochemistry, molecular biology and genetic deficiency
KV Venkatachalam
IUBMB LIFE (2003)
Sulfo-glycosaminoglycan content affects PHF-tau solubility and allows the identification of different types of PHFs
F Hernández et al.
BRAIN RESEARCH (2002)
Tau blocks traffic of organelles, neurofilaments, and APP vesicles in neurons and enhances oxidative stress
K Stamer et al.
JOURNAL OF CELL BIOLOGY (2002)
Share Paper
